The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects
Open accessAbstract
The use of evidence from clinical trials to support decisions for individual patients is a form of “reference class forecasting”: implicit predictions for an individual are made on the basis of outcomes in a reference class of “similar” patients treated with alternative therapies. Evidence based medicine has generally emphasized the broad reference class of patients qualifying for a trial. Yet patients in a trial (and in clinical practice) differ from one another in many ways that can affect the outcome of interest and the potential for benefit. The central goal of personalized medicine, in its various forms, is to narrow the reference class to yield more patient specific effect estimates to support more individualized clinical decision making. This article will review fundamental conceptual problems with the prediction of outcome risk and heterogeneity of treatment effect (HTE), as well as the limitations of conventional (one-variable-at-a-time) subgroup analysis. It will also discuss several regression based approaches to “predictive” heterogeneity of treatment effect analysis, including analyses based on “risk modeling” (such as stratifying trial populations by their risk of the primary outcome or their risk of serious treatment-related harms) and analysis based on “effect modeling” (which incorporates modifiers of relative effect). It will illustrate these approaches with clinical examples and discuss their respective strengths and vulnerabilities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Baker, S. G., & Sargent, D. J. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq427 · Cited by 19
RetractedRegression shrinkage and selection via the lasso
Tibshirani, R. (1996) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1996.tb02080.x · Cited by 51,482
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
(2011) · Cited by 14,317
Why Most Published Research Findings Are False
Ioannidis, J. P. A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020124 · Cited by 10,505
Ridge regression: Biased estimation for nonorthogonal problems
Hoerl, A. E., & Kennard, R. W. (1970) · Technometrics · doi:10.1080/00401706.1970.10488634 · Cited by 9,648
Harrell, F. E. (2001) · Springer Series in Statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,195
Harrell (2015) · Springer Series in Statistics · doi:10.1007/978-3-319-19425-7 · Cited by 6,878
Decision curve analysis: a novel method for evaluating prediction models
Vickers, A. J., & Elkin, E. B. (2006) · Medical Decision Making · doi:10.1177/0272989x06295361 · Cited by 6,341
Statistics and Causal Inference
Holland, P. W. (1986) · Journal of the American Statistical Association · doi:10.1080/01621459.1986.10478354 · Cited by 5,293
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.005 · Cited by 4,945
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
Why Most Published Research Findings Are False
Ioannidis, J. P. A. (2005) · CHANCE · doi:10.1080/09332480.2005.10722754 · Cited by 4,702
Serruys, P. W., Morice, M.-C., Kappetein, A. P., Colombo, A., Holmes, D. R., Mack, M. J., Ståhle, E., Feldman, T. E., van den Brand, M., Bass, E. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804626 · Cited by 4,331
Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437741.48606.98 · Cited by 3,697
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · Cited by 3,322
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · British Journal of Cancer · doi:10.1038/bjc.2014.639 · Cited by 3,293
Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating
Steyerberg, E. W. (2019) · Statistics for Biology and Health · doi:10.1007/978-3-030-16399-0 · Cited by 3,281
Self-citationAntman, E. M., Cohen, M., Bernink, P. J. L. M., McCabe, C. H., Horacek, T., Papuchis, G., Mautner, B., Corbalan, R., Radley, D., & Braunwald, E. (2000) · JAMA · doi:10.1001/jama.284.7.835 · Cited by 3,242
Beta blockade during and after myocardial infarction: An overview of the randomized trials
Yusuf, S., Peto, R., Lewis, J., Collins, R., & Sleight, P. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(85)80003-7 · Cited by 3,205
Antiplatelet Trialists' Collaboration (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 3,126
Estimation and Inference of Heterogeneous Treatment Effects using Random Forests
Wager, S., & Athey, S. (2018) · Journal of the American Statistical Association · doi:10.1080/01621459.2017.1319839 · Cited by 2,917
Sleight, R. B., Sleight, P., Parish, S., Appleby, P. N., Collins, R., & Baigent, C. (1988) · PubMed · Cited by 2,868
急性心筋梗塞の疑いのある17187症例におけるストレプトキナーゼ静脈内投与,アスピリン経口投与,上記2つの併用または無処置の無作偽試験 ISIS-2
Dienstl, F., Backer, G. D., Cairns, J., Pedersen, F., Kala, R., Boissel, J., Schroeder, R., Horgan, J., & Tognoni, G. (1988) · The Lancet · Cited by 2,754
Regularization Paths for Cox's Proportional Hazards Model via Coordinate Descent
Simon, N., Friedman, J., Hastie, T., & Tibshirani, R. (2011) · Journal of Statistical Software · doi:10.18637/jss.v039.i05 · Cited by 2,499
Clinical versus statistical prediction: A theoretical analysis and a review of the evidence.
Meehl, P. E. (1954) · University of Minnesota Press eBooks · doi:10.1037/11281-000 · Cited by 2,171
Yusuf, S., Zucker, D., Passamani, E., Peduzzi, P., Takaro, T., Fisher, L. D., Kennedy, J. W., Davis, K., Killip, T., Norris, R., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91963-1 · Cited by 2,134
Cannon, C. P., Weintraub, W. S., Demopoulos, L. A., Vicari, R., Frey, M. J., Lakkis, N., Neumann, F.-J., Robertson, D. H., DeLucca, P. T., DiBattiste, P. M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106213442501 · Cited by 2,103
Timid choices and bold forecasts: a cognitive perspective on risk taking.
Kahneman, D., & Lovallo, D. (1993) · Management Science · doi:10.1287/mnsc.39.1.17 · Cited by 2,043
Ridge Estimators in Logistic Regression
Cessie, S. L., & Houwelingen, J. C. V. (1992) · Applied Statistics · doi:10.2307/2347628 · Cited by 1,680
Recursive partitioning for heterogeneous causal effects
Athey, S., & Imbens, G. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510489113 · Cited by 1,586
Why Most Discovered True Associations Are Inflated
Ioannidis, J. P. A. (2008) · Epidemiology · doi:10.1097/ede.0b013e31818131e7 · Cited by 1,495
Steyerberg, E. W. (2009) · Statistics for Biology and Health · doi:10.1007/978-0-387-77244-8 · Cited by 1,491
Self-citationStatistics in Medicine — Reporting of Subgroup Analyses in Clinical Trials
Wang, R., Lagakos, S. W., Ware, J. H., Hunter, D. J., & Drazen, J. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmsr077003 · Cited by 1,445
A Comparison of Coronary Angioplasty with Fibrinolytic Therapy in Acute Myocardial Infarction
Andersen, H. R., Nielsen, T. T., Rasmussen, K., Thuesen, L., Kelbaek, H., Thayssen, P., Abildgaard, U., Pedersen, F., Madsen, J. K., Grande, P., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025142 · Cited by 1,322
Timid Choices and Bold Forecasts: A Cognitive Perspective on Risk Taking
Kahneman, D., & Lovallo, D. (2000) · Choices, Values, and Frames · doi:10.1017/cbo9780511803475.023 · Cited by 1,277
Costa, F., van Klaveren, D., James, S., Heg, D., Räber, L., Feres, F., Pilgrim, T., Hong, M.-K., Kim, H.-S., Colombo, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30397-5 · Cited by 1,184
Self-citationSubgroup analysis and other (mis)uses of baseline data in clinical trials
Assmann, S. F., Pocock, S. J., Enos, L. E., & Kasten, L. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02039-0 · Cited by 1,167
Vickers, A. J., Van Calster, B., & Steyerberg, E. W. (2016) · BMJ · doi:10.1136/bmj.i6 · Cited by 1,163
Self-citationPocock, S. J., Assmann, S. E., Enos, L. E., & Kasten, L. E. (2002) · Statistics in Medicine · doi:10.1002/sim.1296 · Cited by 1,077
Balancing Covariates via Propensity Score Weighting
Li, F., Morgan, K. L., & Zaslavsky, A. M. (2018) · Journal of the American Statistical Association · doi:10.1080/01621459.2016.1260466 · Cited by 962
Subgroup analysis in randomised controlled trials: importance, indications, and interpretation
Rothwell, P. M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17709-5 · Cited by 942
Yeh, R. W., Secemsky, E. A., Kereiakes, D. J., Normand, S.-L. T., Gershlick, A. H., Cohen, D. J., Spertus, J. A., Steg, P. G., Cutlip, D. E., Rinaldi, M. J., et al. (2016) · JAMA · doi:10.1001/jama.2016.3775 · Cited by 934
Early versus delayed invasive intervention in acute coronary syndromes
Mehta, S. R., Granger, C. B., Boden, W. E., Steg, P. G., Bassand, J.-P., Faxon, D. P., Afzal, R., Chrolavicius, S., Jolly, S. S., Widimsky, P., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807986 · Cited by 925
A consumer's guide to subgroup analyses
Oxman, A. D., & Guyatt, G. H. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-78 · Cited by 914
Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death
Abraham, E., Laterre, P.-F., Garg, R., Levy, H., Talwar, D., Trzaskoma, B. L., François, B., Guy, J. S., Brückmann, M., Rea-Neto, Á., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050935 · Cited by 890
Farooq, V., van Klaveren, D., Steyerberg, E. W., Meliga, E., Vergouwe, Y., Chieffo, A., Kappetein, A. P., Colombo, A., Holmes, D. R., Mack, M., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60108-7 · Cited by 840
Self-citationMehta, S. R., Cannon, C. P., Fox, K. A. A., Wallentin, L., Boden, W. E., Spacek, R., Widimsky, P., McCullough, P. A., Hunt, D., Braunwald, E., et al. (2005) · JAMA · doi:10.1001/jama.293.23.2908 · Cited by 827
Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses
Sun, X., Briel, M., Walter, S. D., & Guyatt, G. H. (2010) · BMJ · doi:10.1136/bmj.c117 · Cited by 808
Ridge Regression: Biased Estimation for Nonorthogonal Problems
Hoerl, A. E., & Kennard, R. W. (2000) · Technometrics · doi:10.1080/00401706.2000.10485983 · Cited by 808
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · Circulation · doi:10.1161/circulationaha.114.014508 · Cited by 793
Subgroup analyses in randomized trials: risks of subgroup-specific analyses;
Brookes, S. T., Whitely, E., Egger, M., Smith, G. D., Mulheran, P. A., & Peters, T. J. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2003.08.009 · Cited by 775
Choi, S. W., Gibbons, L. E., & Crane, P. K. (2011) · Journal of Statistical Software · doi:10.18637/jss.v039.i08 · Cited by 755
Coronary Intervention for Persistent Occlusion after Myocardial Infarction
Hochman, J. S., Lamas, G. A., Buller, C. E., Dzavik, V., Reynolds, H. R., Abramsky, S. J., Forman, S., Ruzyllo, W., Maggioni, A. P., White, H., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066139 · Cited by 732
Strong Rules for Discarding Predictors in Lasso-Type Problems
Tibshirani, R., Bien, J., Friedman, J., Hastie, T., Simon, N., Taylor, J., & Tibshirani, R. J. (2012) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.1467-9868.2011.01004.x · Cited by 653
Testing for Qualitative Interactions between Treatment Effects and Patient Subsets
Gail, M., & Simon, R. (1985) · Biometrics · doi:10.2307/2530862 · Cited by 651
An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke
Kent, D. M., Ruthazer, R., Weimar, C., Mas, J.-L., Serena, J., Homma, S., Di Angelantonio, E., Di Tullio, M. R., Lutz, J. S., Elkind, M. S. V., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a08d59 · Cited by 637
Self-citationEvidence‐Based Medicine, Heterogeneity of Treatment Effects, and the Trouble with Averages
KRAVITZ, R. L., DUAN, N., & BRASLOW, J. (2004) · The Milbank Quarterly · doi:10.1111/j.0887-378x.2004.00327.x · Cited by 602
Krumholz, H. M. (2014) · Health Affairs · doi:10.1377/hlthaff.2014.0053 · Cited by 589
Brookes, S. T., Whitley, E., Peters, T. J., Mulheran, P. A., Egger, M., & Davey Smith, G. (2001) · Health Technology Assessment · doi:10.3310/hta5330 · Cited by 580
Targeting of Low-Dose CT Screening According to the Risk of Lung-Cancer Death
Kovalchik, S. A., Tammemagi, M., Berg, C. D., Caporaso, N. E., Riley, T. L., Korch, M., Silvestri, G. A., Chaturvedi, A. K., & Katki, H. A. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301851 · Cited by 575
Prognosis research strategy (PROGRESS) 4: Stratified medicine research
Hingorani, A. D., Windt, D. A. V. D., Riley, R. D., Abrams, K., Moons, K. G. M., Steyerberg, E. W., Schroter, S., Sauerbrei, W., Altman, D. G., Hemingway, H., et al. (2013) · BMJ · doi:10.1136/bmj.e5793 · Cited by 510
Self-citationKent, D. M., & Hayward, R. A. (2007) · JAMA · doi:10.1001/jama.298.10.1209 · Cited by 505
Self-citationAssessing and reporting heterogeneity in treatment effects in clinical trials: a proposal
Kent, D. M., Rothwell, P. M., Ioannidis, J. P., Altman, D. G., & Hayward, R. A. (2010) · Trials · doi:10.1186/1745-6215-11-85 · Cited by 504
Self-citationThe Challenge of Subgroup Analyses — Reporting without Distorting
Lagakos, S. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068070 · Cited by 504
Making trials matter: pragmatic and explanatory trials and the problem of applicability
Treweek, S., & Zwarenstein, M. (2009) · Trials · doi:10.1186/1745-6215-10-37 · Cited by 482
Optum Labs: Building A Novel Node In The Learning Health Care System
Wallace, P. J., Shah, N. D., Dennen, T., Bleicher, P. A., & Crown, W. H. (2014) · Health Affairs · doi:10.1377/hlthaff.2014.0038 · Cited by 445
Prediction of benefit from carotid endar terectomy in individual patients: a risk-modelling study
Rothwell, P., & Warlow, C. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11415-0 · Cited by 411
Credibility of claims of subgroup effects in randomised controlled trials: systematic review
Sun, X., Briel, M., Busse, J. W., You, J. J., Akl, E. A., Mejza, F., Bala, M. M., Bassler, D., Mertz, D., Diaz-Granados, N., et al. (2012) · BMJ · doi:10.1136/bmj.e1553 · Cited by 395
An evidence based approach to individualising treatment
Glasziou, P. P., & Irwig, L. M. (1995) · BMJ · doi:10.1136/bmj.311.7016.1356 · Cited by 391
Developing a Protocol for Observational Comparative Effectiveness Research: A User's Guide
Velentgas, P., Dreyer, N. A., Nourjah, P. A., Smith, S. R., & Torchia, M. (2013) · Cited by 380
Furukawa, T. A., Guyatt, G. H., & Griffith, L. E. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.72 · Cited by 318
When and how can real world data analyses substitute for randomized controlled trials?
Franklin, J. M., & Schneeweiss, S. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.857 · Cited by 316
Balancing Covariates via Propensity Score WeightingPreprint
Li, F., Lock, K., Alan, M., & Zaslavsky, M. (2014) · Cited by 314
Can overall results of clinical trials be applied to all patients?
Rothwell, P. M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90120-5 · Cited by 313
Three simple rules to ensure reasonably credible subgroup analyses
Burke, J. F., Sussman, J. B., Kent, D. M., & Hayward, R. A. (2015) · BMJ · doi:10.1136/bmj.h5651 · Cited by 312
Self-citationModerators of Treatment Outcomes: Clinical, Research, and Policy Importance
Kraemer, H. C., Frank, E., & Kupfer, D. J. (2006) · JAMA · doi:10.1001/jama.296.10.1286 · Cited by 310
Prediction of Mode of Death in Heart Failure: The Seattle Heart Failure Model
Mozaffarian, D., Anker, S. D., Anand, I., Linker, D. T., Sullivan, M. D., Cleland, J. G. F., Carson, P. E., Maggioni, A. P., Mann, D. L., Pitt, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.687103 · Cited by 301
Tutorial in biostatistics: data‐driven subgroup identification and analysis in clinical trials
Lipkovich, I., Dmitrienko, A., & B., R. (2017) · Statistics in Medicine · doi:10.1002/sim.7064 · Cited by 291
From subgroups to individuals: general principles and the example of carotid endarterectomy
Rothwell, P. M., Mehta, Z., Howard, S. C., Gutnikov, S. A., & Warlow, C. P. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17746-0 · Cited by 281
Venn, J. (1964) · Biometrika · doi:10.2307/2334241 · Cited by 267
Bryant, J., Clegg, A., Nicholson, T., McIntyre, L., De Broe, S., Gerard, K., & Waugh, N. (2001) · Health Technology Assessment · doi:10.3310/hta5010 · Cited by 246
Analysis of randomized comparative clinical trial data for personalized treatment selections
Cai, T., Tian, L., Wong, P. H., & Wei, L. J. (2011) · Biostatistics · doi:10.1093/biostatistics/kxq060 · Cited by 239
Morrow, D. (2002) · European Heart Journal · doi:10.1053/euhj.2001.2738 · Cited by 225
Some methods for heterogeneous treatment effect estimation in high dimensions
Powers, S., Qian, J., Jung, K., Schuler, A., Shah, N. H., Hastie, T., & Tibshirani, R. (2018) · Statistics in Medicine · doi:10.1002/sim.7623 · Cited by 202
Hayward, R. A., Kent, D. M., Vijan, S., & Hofer, T. P. (2006) · BMC Medical Research Methodology · doi:10.1186/1471-2288-6-18 · Cited by 196
Self-citationDeconvolution Estimation in Measurement Error Models: The R Package decon
Wang, X.-F., & Wang, B. (2011) · Journal of Statistical Software · doi:10.18637/jss.v039.i10 · Cited by 194
Dahabreh, I. J., Hayward, R. A., & Kent, D. M. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw125 · Cited by 189
Self-citationKent, D. M., Nelson, J., Dahabreh, I. J., Rothwell, P. M., Altman, D. G., & Hayward, R. A. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw118 · Cited by 187
Self-citationAdjusted Analyses in Studies Addressing Therapy and Harm: Users’ Guides to the Medical Literature
Agoritsas, T., Merglen, A., Shah, N. D., O’Donnell, M., & Guyatt, G. H. (2017) · JAMA · doi:10.1001/jama.2016.20029 · Cited by 184
Effectively Selecting a Target Population for a Future Comparative Study
Zhao, L., Tian, L., Cai, T., Claggett, B., & Wei, L. J. (2013) · Journal of the American Statistical Association · doi:10.1080/01621459.2013.770705 · Cited by 180
Dorresteijn, J. A. N., Visseren, F. L. J., Ridker, P. M., Wassink, A. M. J., Paynter, N. P., Steyerberg, E. W., van der Graaf, Y., & Cook, N. R. (2011) · BMJ · doi:10.1136/bmj.d5888 · Cited by 177
Self-citationStatistical inference for the mean outcome under a possibly non-unique optimal treatment strategy
Luedtke, A. R., & van der Laan, M. J. (2016) · The Annals of Statistics · doi:10.1214/15-aos1384 · Cited by 173
Kent, D. M., Selker, H. P., Ruthazer, R., Bluhmki, E., & Hacke, W. (2006) · Stroke · doi:10.1161/01.str.0000249054.96644.c6 · Cited by 168
Self-citationVaradhan, R., Segal, J. B., Boyd, C. M., Wu, A. W., & Weiss, C. O. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.02.009 · Cited by 151
Wallach, J. D., Sullivan, P. G., Trepanowski, J. F., Sainani, K. L., Steyerberg, E. W., & Ioannidis, J. P. A. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.9125 · Cited by 148
Self-citationSussman, J. B., Kent, D. M., Nelson, J. P., & Hayward, R. A. (2015) · BMJ · doi:10.1136/bmj.h454 · Cited by 143
Thune, J. J., Hoefsten, D. E., Lindholm, M. G., Mortensen, L. S., Andersen, H., Nielsen, T. T., Køber, L., & Kelbæk, H. (2005) · Circulation · doi:10.1161/circulationaha.105.558676 · Cited by 139
Venema, E., Mulder, M. J. H. L., Roozenbeek, B., Broderick, J. P., Yeatts, S. D., Khatri, P., Berkhemer, O. A., Emmer, B. J., Roos, Y. B. W. E. M., Majoie, C. B. L. M., et al. (2017) · BMJ · doi:10.1136/bmj.j1710 · Cited by 135
Self-citationSubgroup analyses in therapeutic cardiovascular clinical trials: Are most of them misleading?
Hernández, A. V., Boersma, E., Murray, G. D., Habbema, J. D. F., & Steyerberg, E. W. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.04.020 · Cited by 131
Self-citationPatient subsets and variation in therapeutic efficacy.
Simon, R. M. (1982) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1982.tb02015.x · Cited by 130
Klaveren, D. V., Steyerberg, E. W., Serruys, P. W. J. C., & Kent, D. M. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.10.021 · Cited by 127
Self-citationTargeted Learning of the Mean Outcome under an Optimal Dynamic Treatment Rule
van der Laan, M. J., & Luedtke, A. R. (2014) · Journal of Causal Inference · doi:10.1515/jci-2013-0022 · Cited by 122
Heterogeneity Is Not Always Noise: Lessons From Improvement
Davidoff, F. (2009) · JAMA · doi:10.1001/jama.2009.1845 · Cited by 118
Vickers, A. J., Kattan, M. W., & Sargent, D. J. (2007) · Trials · doi:10.1186/1745-6215-8-14 · Cited by 117
RoPE Study Investigators, Kent, D. M., & Thaler, D. E. (2011) · Trials · doi:10.1186/1745-6215-12-185 · Cited by 109
Self-citationHeberden Oration, 1965 . Reflections on the Controlled Trial
Hill, A. B. (1966) · Annals of the Rheumatic Diseases · doi:10.1136/ard.25.2.107 · Cited by 106
Risk-Targeted Lung Cancer Screening
Kumar, V., Cohen, J. T., Klaveren, D. V., Soeteman, D. I., Wong, J. B., Neumann, P. J., & Kent, D. M. (2018) · Annals of Internal Medicine · doi:10.7326/m17-1401 · Cited by 106
Self-citationHow to work with a subgroup analysis.
Dijkman, B. G., Dr. Bauke Kooistra, O. S., & Bhandari, M. (2009) · PubMed · Cited by 98
Assessing apparent treatment—covariate interactions in randomized clinical trials
Byar, D. P. (1985) · Statistics in Medicine · doi:10.1002/sim.4780040304 · Cited by 95
Reporting Clinical Trial Results To Inform Providers, Payers, And Consumers
Hayward, R. A., Kent, D. M., Vijan, S. S., & Hofer, T. P. (2005) · Health Affairs · doi:10.1377/hlthaff.24.6.1571 · Cited by 93
Self-citationBurke, J. F., Hayward, R. A., Nelson, J., & Kent, D. M. (2014) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000497 · Cited by 91
Self-citationTannock, I. F. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.3-4.206 · Cited by 90
Subgroup analyses in confirmatory clinical trials: time to be specific about their purposes
Tanniou, J., van der Tweel, I., Teerenstra, S., & Roes, K. C. B. (2016) · BMC Medical Research Methodology · doi:10.1186/s12874-016-0122-6 · Cited by 90
Wallach, J. D., Sullivan, P. G., Trepanowski, J. F., Steyerberg, E. W., & Ioannidis, J. P. A. (2016) · BMJ · doi:10.1136/bmj.i5826 · Cited by 89
Self-citationStewart, A., Sandercock, J., Bryan, S., Hyde, C., Barton, P. M., Fry-Smith, A., & Burls, A. (2001) · Health Technology Assessment · doi:10.3310/hta5020 · Cited by 89
Atypical femoral fractures and bisphosphonate use: current evidence and clinical implications
Saita, Y., Ishijima, M., & Kaneko, K. (2015) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622315584114 · Cited by 86
A Historic Moment for Open Science: The Yale University Open Data Access Project and Medtronic
Krumholz, H. M., Ross, J. S., Gross, C. P., Emanuel, E. J., Hodshon, B., Ritchie, J. D., Low, J. B., & Lehman, R. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-12-201306180-00009 · Cited by 86
Selker, H. P., Griffith, J. L., Beshansky, J. R., Schmid, C. H., Califf, R. M., D’Agostino, R. B., Laks, M. M., Lee, K. L., Maynard, C. C., Selvester, R. H. S., et al. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-7-199710010-00006 · Cited by 84
Probability at the Bedside: The Knowing of Chances or the Chances of Knowing?
Goodman, S. N. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-7-199904060-00022 · Cited by 83
Selection of thrombolytic therapy for individual patients: Development of a clinical model
Califf, R. M., Woodlief, L. H., Harrell, F. E., Lee, K. L., White, H. D., Guerci, A. D., Barbash, G. I., Simes, R. J., Weaver, W. D., Simoons, M. L., et al. (1997) · American Heart Journal · doi:10.1016/s0002-8703(97)70164-9 · Cited by 82
Basu, S., Sussman, J. B., Rigdon, J., Steimle, L., Denton, B. T., & Hayward, R. A. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002410 · Cited by 77
Using Design Thinking to Differentiate Useful From Misleading Evidence in Observational Research
Goodman, S. N., Schneeweiß, S., & Baiocchi, M. (2017) · JAMA · doi:10.1001/jama.2016.19970 · Cited by 75
Can the Learning Health Care System Be Educated With Observational Data?
Dahabreh, I. J., & Kent, D. M. (2014) · JAMA · doi:10.1001/jama.2014.4364 · Cited by 71
Self-citationHow to translate clinical trial results into gain in healthy life expectancy for individual patients
Dorresteijn, J. A. N., Kaasenbrood, L., Cook, N. R., van Kruijsdijk, R. C. M., van der Graaf, Y., Visseren, F. L. J., & Ridker, P. M. (2016) · BMJ · doi:10.1136/bmj.i1548 · Cited by 64
Optimal Individualized Treatments in Resource-Limited Settings
Luedtke, A. R., & van der Laan, M. J. (2016) · The International Journal of Biostatistics · doi:10.1515/ijb-2015-0007 · Cited by 64
Selker, H. P., Beshansky, J. R., Griffith, J. L., & for the TPI Trial Investigators* (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-2-200207160-00006 · Cited by 63
Kent, D. M., Hayward, R. A., Griffith, J. L., Vijan, S. S., Beshansky, J. R., Califf, R. M., & Selker, H. P. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01160-9 · Cited by 62
Self-citationSun, X., Briel, M., Busse, J. W., Akl, E. A., You, J. J., Mejza, F., Bała, M. M., Diaz-Granados, N., Bassler, D., Mertz, D., et al. (2009) · Trials · doi:10.1186/1745-6215-10-101 · Cited by 59
Assessing Treatment‐Selection Markers using a Potential Outcomes Framework
Huang, Y., Gilbert, P. B., & Janes, H. (2012) · Biometrics · doi:10.1111/j.1541-0420.2011.01722.x · Cited by 58
The use and abuse of subgroup analysis in epidemiological research
Stallones, R. A. (1987) · Preventive Medicine · doi:10.1016/0091-7435(87)90082-x · Cited by 57
Subgroups, treatment effects, and baseline risks: Some lessons from major cardiovascular trials
Parker, A. B., & Naylor, C. D. (2000) · American Heart Journal · doi:10.1067/mhj.2000.106610 · Cited by 57
Competing risk and heterogeneity of treatment effect in clinical trials
Kent, D. M., Alsheikh-Ali, A. A. A., & Hayward, R. A. (2008) · Trials · doi:10.1186/1745-6215-9-30 · Cited by 55
Self-citationKent, D. M., Ruthazer, R., & Selker, H. P. (2003) · Stroke · doi:10.1161/01.str.0000051506.43212.8b · Cited by 54
Self-citationKlaveren, D. V., Vergouwe, Y., Farooq, V., Serruys, P. W. J. C., & Steyerberg, E. W. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.02.012 · Cited by 52
Self-citationRisk Models and Patient-Centered Evidence
Shah, N. D. (2012) · JAMA · doi:10.1001/jama.2012.469 · Cited by 46
Endogenous Stratification in Randomized Experiments
Abadie, A., Chingos, M. M., & West, M. R. (2013) · National Bureau of Economic Research · doi:10.3386/w19742 · Cited by 46
Testing for Interaction in an I × J × K Contingency Table
Halperin, M., Ware, J. H., Byar, D. P., Mantel, N., Brown, C. C., Koziol, J. A., Gail, M. H., & B., G. S. (1977) · Biometrika · doi:10.1093/biomet/64.2.271 · Cited by 45
Cd, F., & Byington, R. P. (1983) · PubMed · Cited by 45
Claggett, B. L., Tian, L., Castagno, D., & Wei, L. J. (2014) · Biostatistics · doi:10.1093/biostatistics/kxu037 · Cited by 43
Dorresteijn, J. A. N., Boekholdt, S. M., van der Graaf, Y., Kastelein, J. J. P., LaRosa, J. C., Pedersen, T. R., DeMicco, D. A., Ridker, P. M., Cook, N. R., & Visseren, F. L. J. (2013) · Circulation · doi:10.1161/circulationaha.112.000712 · Cited by 43
The Fundamental Difficulty With Evaluating the Accuracy of Biomarkers for Guiding Treatment
Janes, H., PEPE, M. S., McShane, L. M., Sargent, D. J., & Heagerty, P. J. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv157 · Cited by 40
The twin questions of personalized medicine: who are you and whom do you most resemble?
Kohane, I. S. (2009) · Genome Medicine · doi:10.1186/gm4 · Cited by 38
More on Subgroup Analyses in Clinical Trials
Pocock, S., & Lubsen, J. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0800616 · Cited by 29
Can Knowledge About Heterogeneity in Treatment Effects Help Us Choose Wisely?
Davidoff, F. (2016) · Annals of Internal Medicine · doi:10.7326/m16-1721 · Cited by 26
Kernan, W. N., Viscoli, C. M., Dearborn, J. L., Kent, D. M., CONWIT, R. A., Fayad, P. B., Furie, K. L., Gorman, M., Guarino, P., Inzucchi, S. E., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.2136 · Cited by 25
Self-citationIs a Subgroup Claim Believable? A User’s Guide to Subgroup Analyses in the Surgical Literature
By the Study to Prospectively Evaluate Reamed Intramedullary Nails in Tibial Fractures (SPRINT) Investigators, Sun, X., Heels‐Ansdell, D., Walter, S. D., Guyatt, G. H., Sprague, S., Bhandari, M., Sanders, D., Schemitsch, E. H., Tornetta, P., et al. (2011) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.i.01555 · Cited by 22
Stern, R. H. (2012) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2012.00592.x · Cited by 21
Raman, G., Balk, E. M., Lai, L. Y. H., Shi, J., Chan, J., Lutz, J. S., Dubois, R. W., Kravitz, R. L., & Kent, D. M. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-017641 · Cited by 20
Self-citationThe ‘number need to treat’: does it help clinical decision making?
Ebrahim, S. B. J., & Smith, G. D. (1999) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000919 · Cited by 17
Profile-specific survival estimates: Making reports of clinical trials more patient-relevant
Julien, M., & Hanley, J. A. (2008) · Clinical Trials · doi:10.1177/1740774508089511 · Cited by 15
Decker, C., Garavalia, L. S., Garavalia, B., Gialde, E., Yeh, R. W., Spertus, J. A., & Chhatriwalla, A. K. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.03.027 · Cited by 15
Scoring System to Optimize Pioglitazone Therapy After Stroke Based on Fracture Risk
Viscoli, C. M., Kent, D. M., CONWIT, R. A., Dearborn, J. L., Furie, K. L., Gorman, M., Guarino, P., Inzucchi, S. E., Stuart, A., Young, L. H., et al. (2018) · Stroke · doi:10.1161/strokeaha.118.022745 · Cited by 15
Self-citationRealizing the Potential of Clinical Risk Prediction Models
Salisbury, A. C., & Spertus, J. A. (2015) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.115.002038 · Cited by 13
Marcucci, M., & Sinclair, J. C. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003143 · Cited by 11
Sinclair, J. C., & Haynes, R. B. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.12.006 · Cited by 9
Testing for Interaction in an I × J × K Contingency Table
Halperin, M., Ware, J. H., Byar, D. P., et al. (1977) · Biometrika · doi:10.2307/2335693 · Cited by 7
Prediction of Incident Diabetes Mellitus in Middle-aged Adults: The Framingham Offspring Study
Wilson, P. W. F. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.10.1068 · Cited by 4
Optimal Dynamic Treatments in Resource-Limited Settings
Luedtke, A. R., & van der Laan, M. J. (2015) · Collection of Biostatistics Research Archive · Cited by 3
Cited by
Rahimi, K., Bidel, Z., Nazarzadeh, M., Copland, E., Canoy, D., Ramakrishnan, R., Pinho-Gomes, A.-C., Woodward, M., Adler, A., Agodoa, L., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00590-0 · Cited by 1,074
SCORE2-OP working group and ESC Cardiovascular risk collaboration, de Vries, T. I., Cooney, M. T., Selmer, R. M., Hageman, S. H. J., Pennells, L. A., Wood, A., Kaptoge, S., Xu, Z., Westerink, J., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab312 · Cited by 622
The Predictive Approaches to Treatment effect Heterogeneity (PATH) statement
Kent, D. M., Paulus, J. K., van Klaveren, D., D'Agostino, R., Goodman, S., Hayward, R., Ioannidis, J. P. A., Patrick-Lake, B., Morton, S., Pencina, M., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m18-3667 · Cited by 469
Self-citationTime to reality check the promises of machine learning-powered precision medicine.
Wilkinson, J., Arnold, K. F., Murray, E. J., van Smeden, M., Carr, K., Sippy, R., de Kamps, M., Beam, A., Konigorski, S., Lippert, C., et al. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30200-4 · Cited by 233
Bickman, L. (2020) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-020-01065-8 · Cited by 184
Metadata
- Authors
- Kent, D. M., Steyerberg, E., & van Klaveren, D.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2018-12-10
- Volume
- 363
- Pages
- k4245
- ISSN
- 1756-1833 (ISSN-L)
- 0959-8138
- OpenAlex
- W2904040183
- Cited by
- 479
- References
- 163
- FWCI
- 30.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.